脂肪性肝炎
脂肪肝
肝细胞癌
肝硬化
医学
脂肪变性
疾病
纤维化
生物信息学
重症监护医学
内科学
生物
作者
Yvonne Oligschlaeger,Ronit Shiri‐Sverdlov
出处
期刊:Biomedicines
[Multidisciplinary Digital Publishing Institute]
日期:2020-02-08
卷期号:8 (2): 28-28
被引量:74
标识
DOI:10.3390/biomedicines8020028
摘要
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI